関: beta-galactosidase

WordNet

to remain unmolested, undisturbed, or uninterrupted -- used only in infinitive form; "let her be"
work in a specific place, with a specific subject, or in a specific function; "He is a herpetologist"; "She is our resident philosopher" (同)follow
have life, be alive; "Our great leader is no more"; "My grandfather lived until the end of war" (同)live
be identical to; be someone or something; "The president of the company is John Smith"; "This is my house"
happen, occur, take place; "I lost my wallet; this was during the visit to my parents house"; "There were two hundred people at his funeral"; "There was a lot of noise in the kitchen"
have the quality of being; (copula, used with an adjective or a predicate noun); "John is rich"; "This is not a good answer"
occupy a certain position or area; be somewhere; "Where is my umbrella?" "The toolshed is in the back"; "What is behind this behavior?"
spend or use time; "I may be an hour"
stake on the outcome of an issue; "I bet $100 on that new horse"; "She played all her money on the dark horse" (同)wager, play
the act of gambling; "he did it on a bet" (同)wager
maintain with or as if with a bet; "I bet she will be there!" (同)wager
second in order of importance; "the candidate, considered a beta male, was perceived to be unable to lead his party to victory"
the 2nd letter of the Greek alphabet
preliminary or testing stage of a software or hardware product; "a beta version"; "beta software"
a unit of gravitational acceleration equal to one centimeter per second per second (named after Galileo)
alliterative term for girl (or woman)
a unit of force equal to the force exerted by gravity; used to indicate the force to which a body is subjected when it is accelerated (同)gee, g-force

PrepTutorEJDIC

《連結語として補語を伴なって…『である』,…だ,…です / 《位置・場所を表す語句を伴って》(…に)『ある』,いる(occupy a place or situation) / 〈物事が〉『存在する』,ある(exist);〈生物が〉生存する,生きている(live) / 行われる,起こる,発生する(take place, occur) / 存続する,そのままでいる(remain as before) / 《『be to』 do》 / …する予定である,…することになっている / …すべきだ / 《受動態の不定詞を伴って》…できる / 《命令》…するのだ / 《条件節に》…する意図がある / 《『if…were to』 do》…するとしたなら / 《『be』 do『ing』》《進行形》 / 《進行中の動作》…している,しつつある / 《近い未来》…しようとしている,するつもり / 《動作の反復》(いつも)…している / 《『be』+『他動詞の過去分詞』》《受動態》…される,されている / 《『be』+『自動詞の過去分詞』》《完了形》…した[状態にある]
『かけ』・(…との)かけ《+『with』+『名』》 / かけた物(金) / かけの対象 / 〈金・物〉'を'『かける』 / (かけ事・ゲームなどで)〈人〉‘と'『かけをする』《+『名』〈人〉+『on』+『名』》 / (…に)『かける』《+『on』(『against』)+『名』(one's do『ing』)》
ベータ(ギリシア語アルファベットの第2文字;B,β;英語のB,b に遭当)
女の子,少女(girl)

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 髄膜炎菌の微生物学および病理生物学microbiology and pathobiology of neisseria meningitidis [show details]
…modified by addition of either an O-linked trisaccharide, Gal (beta 1,4) Gal (alpha 1,3) 2,4-diacetamido-2,4,6-trideoxyhexose, or an O-linked disaccharide Gal (alpha 1,3) GlcNAc . Other studies indicate that phosphorylcholine…
2. 食物アレルギーの新規治療法：特異的免疫療法と非特異的免疫療法investigational therapies for food allergy immunotherapy and nonspecific therapies [show details]
…immunization with a mixture of ISS and beta-galactosidase (beta-gal), but not with either alone, provided protection against fatal anaphylaxis induced by intraperitoneal beta-gal sensitization and challenge . …
3. プライマリケアの最新情報whats new in primary care [show details]
…hypertension, beta-blocker use in the first trimester was not associated with an increased risk for major malformations overall or for cardiac malformations compared with nonexposure (unfilled beta-blocker prescription) …
4. 家庭医学の最新情報whats new in family medicine [show details]
…hypertension, beta-blocker use in the first trimester was not associated with an increased risk for major malformations overall or for cardiac malformations compared with nonexposure (unfilled beta-blocker prescription) …
5. βサラセミアの病態生理pathophysiology of beta thalassemia [show details]
… manifestations of severe thalassemia. Beta⁺ thalassemia refers to mutations that cause decreased (but not absent) beta globin production. Patients who are homozygous for beta⁺ thalassemia mutations …

English Journal

Malvidin attenuates pain and inflammation in rats with osteoarthritis by suppressing NF-κB signaling pathway.

Dai T1, Shi K1, Chen G1, Shen Y1, Pan T2.
Inflammation research : official journal of the European Histamine Research Society ... [et al.].Inflamm Res.2017 Dec;66(12):1075-1084. doi: 10.1007/s00011-017-1087-6. Epub 2017 Aug 29.
PMID 28852776

Porous chitosan beads of superior mechanical properties for the covalent immobilization of enzymes.

Wahba MI1.
International journal of biological macromolecules.Int J Biol Macromol.2017 Dec;105(Pt 1):894-904. doi: 10.1016/j.ijbiomac.2017.07.102. Epub 2017 Jul 18.
PMID 28732732

A novel high throughput screening assay for binding affinities of perfluoroalkyl iodide for estrogen receptor alpha and beta isoforms.

Song W1, Zhao L2, Sun Z2, Yang X2, Zhou Q3, Jiang G2.
Talanta.Talanta.2017 Dec 1;175:413-420. doi: 10.1016/j.talanta.2017.07.068. Epub 2017 Jul 25.
PMID 28842010

Japanese Journal

Activation of p53 by Nutlin-3a, an antagonist of MDM2, induces apoptosis and cellular senescence in adult T-cell leukemia cells.

Hasegawa Hiroo,Yamada Yasuaki,Iha Hidekatsu,Tsukasaki Kunihiro,Nagai Kazuhiro,Atogami Sunao,Sugahara Kazuyuki,Tsuruda Kazuto,Ishizaki Akiko,Kamihira Shimeru
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 23(11), 2090-2101, 2009-11
… Interestingly, senescence-associated-beta-galactosidase (SA-beta-gal) staining revealed that only ATL-related cell lines with wild-type p53 showed cellular senescence, although they lack both p16(INK4a) and p14(ARF). …
NAID 120002180695

Effectiveness of intragastric immunization with protein and oligodeoxynucleotides containing a CpG motif for inducing a gastrointestinal mucosal immune response in mice

引地拓人,小林浩子,大山仁,山本豪,渡辺浩志,入澤篤志,小原勝敏,佐藤由紀夫
Fukushima Journal of Medical Science 51(1), 19-31, 2005-06
… METHODS: Mice were immunized with beta-galactosidase (beta-gal) and synthesized oligodeoxynucleotides containing a CpG motif (CpG-DNA) by intragastric injection, and the immune response was compared with those induced by 3 other immunization forms: intranasal, oral, and intradermal. …
NAID 110001258552

The expression of IV6 .BETA.(Gal.BETA.1-4(Fuc.ALPHA.1-3)GlcNAc)-Gb5Cer in mouse kidney is controlled by the Gsl-5 gene through regulation of UDP-GlcNAc:Gb5Cer .BETA.1-6N-acetylglucosaminyltransferase activity.

Sekine Michiko,Hashimoto Yasuhiro,Inagaki Fuyuhiko,Yamakawa Tamio,Suzuki Akemi
The Journal of Biochemistry 108(1), 103-108, 1990
… Thus, we conclude that Gsl-5 controls the expression of GL-Y through regulation of the β1-6G1cNAc transferase activity, and consequently DBA/2 mice cannot express IV6βGlcNAc-Gb5 Cer and IV6β(Galβ1-4GlcNAc)-Gb5 Cer either. …
NAID 130003531128